Case Study: PLD | Stephens

Who We Are

What We Do

We provide investment banking, research, sales and trading, asset and wealth management, public finance, insurance, private capital, and family office services.

About Us

We are a family-owned financial services firm that values client relationships, long-term stability, and supporting the communities where we live and work.

The Stephens Story

The idea of family defines our culture, because each of us knows that our reputation is on the line as if our own name was on the door.


Our reputation as a leading independent financial services firm is built on the stability of our longstanding and highly experienced senior executives.

Impact Initiatives

We are committed to corporate philanthropy; economic and financial literacy advocacy; and diversity, equity, and inclusion initiatives.

Our Brand Ambassadors

Stephens is proud to sponsor the PGA TOUR, LPGA Tour, and PGA TOUR Champions careers, as well as applaud the philanthropic endeavors, of our Brand Ambassadors.

Making Connections

We host many highly informative meetings each year with clients, industry decision makers, and thought leaders across the U.S. and in Europe.

Our Businesses

Capital Management

We provide fiduciary investment strategies to public-and private-sector institutional clients through asset allocation, consulting, and retirement services.

Fixed Income Sales & Trading

Decades of proven performance and experience in providing tailored fixed income trading and underwriting services to major municipal and corporate issuers.

Institutional Equities and Research

Proven industry-leading research, global market insights, and client-focused execution.


Customized risk management, property & casualty, executive strategies and employee benefits solutions that protect our clients over the long term.

Investment Banking

We assist companies with accessing capital through innovative advisory and execution services that help firms achieve their strategic goals.

Private Capital

We have been a trusted and reliable source of capital for private companies for over 70 years.

Private Wealth Management

Our experienced Private Client Group professionals develop customized investment strategies to help clients achieve their financial goals.

Public Finance

We are a trusted municipal advisor with proven expertise in public financings. We also work with clients in negotiated and competitive municipal underwritings.

Ownership Interests

Case Study: PLD

May 10, 2022

In 2010, Stephens Capital Partners (SCP) partnered with management to acquire control of Aaron Industries, a South Carolina based manufacturer of private label pharmaceutical and first-aid products. At the time, Aaron’s product line was predominantly liquid based and included cough cold, allergy, digestive health, oral electrolyte solutions, and personal sanitization items that were manufactured in South Carolina and California.

In 2013, Aaron was acquired by PLD, also a private label manufacturer and distributor, with a focus on solid dose products, which was owned solely by the Singer family, based in Westbury, Long Island. In order to facilitate the financing of the merger, SCP rolled a majority of its investment into the newly formed company. The combined company became the second-largest provider of store branded (generic) consumer healthcare products to U.S. retailers. Post-merger, SCP become the first non-family shareholder of PLD and joined the board, under the leadership of Mitch Singer and his sons Evan and Adam.

Over the past 10 years the company has grown significantly, both organically and through key strategic M&A. In 2019, with the support of SCP – which invested additional capital into the business – PLD acquired the U.S. over-the-counter business of Teva Pharmaceuticals, including its nicotine replacement therapy business and a basket of OTC pharmaceutical products.

Offering more than 300 unique products, including over 60 FDA approved Abbreviated New Drug Applications (ANDAs), PLD is clearly established as the second largest provider of store branded consumer healthcare products to U.S. retailers. In fact, PLD serves every single retailer of consequence that offers its own brand program across all key retailing channels (Food, Drug, Mass, Club, Discount, Convenience and E-commerce).

In 2020, PLD merged with its sister company Avema Pharma Solutions. This transaction combined Avema’s drug development and contract manufacturing capabilities with PLD’s impressive scale in product portfolio and manufacturing capabilities. The combined company is now a leading provider of Contract Development and Manufacturing Organization (CDMO) services to global consumer healthcare and pharmaceutical companies.

In 2022, the company expects to generate $600+ million of revenue across 300 unique products and more than 20 billion dosages sold. The impressive scale of the business is supported by a network of FDA-registered pharmaceutical manufacturing, packaging, and distribution facilities totaling over 2 million square feet.

With SCP’s support, PLD maintains a robust balance sheet with which the company continues to make strategic investments to bring high quality products, capabilities, and services to its impressive roster of clients.

  1. Information is current as of May 10, 2022 This material has been prepared solely for informative purposes as of its stated date and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from sources that we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. No subsequent publication or distribution of this material shall mean or imply that any such information or opinion remains current at any time after the stated date of the material. We do not undertake to advise you of any changes in any such information or opinion.